|
Delayed
Toronto S.E.
08:00:00 02/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.1250 CAD | +4.17% |
|
+4.17% | -26.47% |
| 31/10 | Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2026 | CI |
| 03/10 | Voyageur Pharmaceuticals Settles CA$192,300 Debt by Issuing Shares | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.95Cr | - | - | - | - | - |
| 1,26300Cr | |||||
| 66TCr | |||||
| 52TCr | |||||
| 39TCr | |||||
| 37TCr |
Select your edition
All financial news and data tailored to specific country editions
